Specifically, chemotherapy when given prior to anti-CD40 is thought to elicit an immunogenic form of tumor cell death and the release of tumor antigens for presentation by APCs, which, when subsequently activated via CD40, prime tumor-specific T cells (2). The gene discussed is CD40; the disease is neoplasm.